More than 40 % of all patients with a history of both ON and myelitis at last follow-up presented with simultaneous myelitis and ON at least once, which is not different from what has been described in AQP4-IgG-positive NMO (42 % according to [34]). This evidence concerns the gene AQP4 and neuromyelitis optica.